Sano Genetics raised €10M in a Series A round in Mar 2022. The company is based in Cambridge, UK. Investors in the round: Episode 1, Margo Georgiadis, MMC Ventures and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.